Atrial fibrillation trials recruiting in Kentucky

All Atrial fibrillation trials nationally

Cities in Kentucky

Recruiting trials in Kentucky

• Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
  NCT06730828 · Phase: Phase 1, Phase 2 · Ages: 20 Years to 85 Years · Sex: All (male and female) · Kentucky: Louisville
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Lexington, Louisville
• Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
  NCT06935591 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Kentucky: Lexington
• BoxX-NoAF Clinical Trial
  NCT06989775 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Kentucky: Louisville
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
  NCT06784466 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Kentucky: Lexington
• Colchicine's Effect on Inflammatory Markers
  NCT07287345 · Phase: Phase 4 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Kentucky: Lexington
• PULSED AF Post-Approval Study
  NCT06578104 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Whitesburg
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Louisville, Saint Matthews
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Lexington
• The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
  NCT06324201 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Louisville
• Tracking Results of Ablations to Combat AF Registry Generation 2
  NCT05111015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kentucky: Louisville